Funded Health Care Startups in Montréal
Disclosed round sizes in Montréal’s funded health care slice cluster tightly at the low millions, with one clear outlier: AlayaCare’s 2021-06-23 round of $…
Disclosed round sizes in Montréal’s funded health care slice cluster tightly at the low millions, with one clear outlier: AlayaCare’s 2021-06-23 round of $183M dwarfs the next-largest disclosed amounts at $2M (Paperplane Therapeutics on 2025-02-18; Aplantex on 2024-08-28; NeuroServo on 2023-06-20; Pathway Medical on 2021-10-14; Medzy on 2020-07-28). Most disclosed checks also sit near the floor of the reported amounts, including several $1M rounds (Gray Oncology Solutions on 2021-08-05; Pathway Medical on 2021-10-14) and a low $40K grant (Emovi on 2022-04-22).
The 13-row set concentrates around “Series Unknown” and “undisclosed” labels: 5 entries are undisclosed (e.g., ex-able on 2024-07-01, 2023-05-04; NURA Medical on 2023-05-04; Statera Medical on 2023-05-04; Intelerad on 2022-07-14) and 3 others are “Series Unknown” (Aplantex 2024-08-28; ex-able 2023-05-04; NURA Medical 2023-05-04), spanning 2020-07-28 (Medzy) through 2025-02-18 (Paperplane Therapeutics).
Most recent rounds
13 shownRelated listings
Frequently asked
What outlier shapes the disclosed deal-size distribution for these Montréal health care startups?
AlayaCare’s disclosed $183M on 2021-06-23 is the only round in the hundreds of millions, and it dwarfs the next-largest disclosed amounts at $2M (e.g., Paperplane Therapeutics on 2025-02-18 and NeuroServo on 2023-06-20). A second low-end anchor is Emovi’s $40K grant on 2022-04-22, far below the $1M–$2M cluster (e.g., Gray Oncology Solutions on 2021-08-05 at $1M).
Do these entries cluster in time, or are they spread evenly across the window shown?
They’re not evenly distributed: three entries share the same round date 2023-05-04—ex-able (undisclosed), NURA Medical (undisclosed), and Statera Medical (undisclosed)—suggesting a concentrated funding/announcement day. Beyond that, the timeline runs from 2020-07-28 (Medzy) to 2025-02-18 (Paperplane Therapeutics), with multiple disclosed entries recurring in the 2021–2023 period (e.g., Gray Oncology Solutions 2021-08-05 at $1M and Pathway Medical 2021-10-14 at $1M).
Are the city labels consistent, or is there evidence of geographic ambiguity within Montréal listings?
Most entries use “Montréal, Quebec, Canada,” but two record “Montreal, Quebec, Canada” without the accent: Statera Medical on 2023-05-04 and Intelerad on 2022-07-14. Given the shared country/region text and repeated “Montreal” spelling, the list appears concentrated in the same metro area despite minor formatting differences.
How much of this list lacks disclosed round amounts or clear round labels?
A substantial share is missing either amount disclosure or round label clarity: 5 entries are explicitly “undisclosed” (ex-able 2024-07-01; ex-able 2023-05-04; NURA Medical 2023-05-04; Statera Medical 2023-05-04; Intelerad 2022-07-14). In addition, several entries show “Series Unknown” (e.g., Aplantex on 2024-08-28 with $2M; and the unlabeled series entries like AlayaCare on 2021-06-23), limiting comparability of stage across the dataset.
Which stage designations recur, and how does the mix compare across disclosed rounds?
Seed appears multiple times with disclosed amounts: Paperplane Therapeutics on 2025-02-18 ($2M), NeuroServo on 2023-06-20 ($2M), and Pathway Medical on 2021-10-14 ($1M). Private Equity appears once with an undisclosed amount (Intelerad on 2022-07-14), while other listed stages include Pre-Seed (Gray Oncology Solutions on 2021-08-05 at $1M) and Grant (Emovi on 2022-04-22 at $40K), with several entries missing stage specificity (e.g., Aplantex 2024-08-28; ex-able 2024-07-01).
Which entries are close in size, and which are clearly separated from the main group?
The main disclosed cluster is $2M (Paperplane Therapeutics on 2025-02-18; Aplantex on 2024-08-28; NeuroServo on 2023-06-20), with additional disclosed points at $1M (Gray Oncology Solutions on 2021-08-05; Pathway Medical on 2021-10-14). The separated positions are AlayaCare at $183M on 2021-06-23 and Emovi at $40K on 2022-04-22, both far from the $1M–$2M band.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.